• Home
  • About Us
    • About Us
    • Subscribe
    • Privacy Policy
  • Advertise
    • Advertise On IP Watch
    • Editorial Calendar
  • Videos
  • Links
  • Help

Intellectual Property Watch

Original news and analysis on international IP policy

  • Copyright
  • Patents
  • Trademarks
  • Opinions
  • People News
  • Venues
    • Bilateral/Regional Negotiations
    • ITU/ICANN
    • United Nations – other
    • WHO
    • WIPO
    • WTO/TRIPS
    • Africa
    • Asia/Pacific
    • Europe
    • Latin America/Caribbean
    • North America
  • Themes
    • Access to Knowledge/ Open Innovation & Science
    • Food Security/ Agriculture/ Genetic Resources
    • Finance
    • Health & IP
    • Human Rights
    • Internet Governance/ Digital Economy/ Cyberspace
    • Lobbying
    • Technical Cooperation/ Technology Transfer
  • Health Policy Watch

WTO TRIPS Council Considers Workshop On Public Health Amendment

02/03/2010 by Kaitlin Mara for Intellectual Property Watch 2 Comments

Share this:

  • Click to share on Twitter (Opens in new window)
  • Click to share on LinkedIn (Opens in new window)
  • Click to share on Facebook (Opens in new window)
  • Click to email this to a friend (Opens in new window)
  • Click to print (Opens in new window)

The World Trade Organization group on intellectual property rights met today and ended early, discussing a potential workshop on an amendment intended to ease access to cheaper generic medicines in countries without a pharmaceutical manufacturing sector, a new proposal from Bolivia, and three separate longstanding IP issues with no major changes.

Countries were unable to agree to hold a workshop on the so-called “paragraph 6” agreement, which allow countries to issue a compulsory licence on drugs primarily intended for export to developing countries in need of cheaper generic versions and unable to manufacture them themselves.

Instead, the chair of the Trade-Related Aspects of Intellectual Property Rights (TRIPS) Council said he will hold informal consultations on the issue, though the details of when and how they will be conducted are not yet decided. The United States appears to be the main opponent of holding a workshop, according to several sources. For more background on this issue, see (IPW, WTO/TRIPS, 1 March 2010).

Several countries also brought up another health issue in order to signal its continuing importance to their delegations, sources said. This issue is the delaying of generic drugs in transit through European ports, on which positions have remained unchanged since the October 2009 TRIPS Council (IPW, WTO/TRIPS, 30 October 2009).

Also today, Martin Glass of Hong Kong was formally named the next chair of the TRIPS Council (though the decision was taken at the General Council on 22 February). A special session of TRIPS dedicated to the mandated creation of an international register on geographical indications (product names associated with a certain place and characteristics) meeting 4 March will open with its new chair, Darlington Mwape of Zambia. Karen Tan of Singapore is the outgoing chair of both meetings.

Positions on the three longstanding TRIPS issues – which have been strategically linked and are supported by a majority of WTO members – have also remained unchanged since the October 2009 TRIPS Council, several sources told Intellectual Property Watch.

These issues include the creation of the GI register, a proposed extension of high-level protection on geographical indications for wines and spirits to other goods (GI extension) and mandated examination of how the TRIPS agreement relates to the UN Convention on Biological Diversity.

On the latter two issues, referred to as “outstanding implementation issues” from the Doha ministerial, WTO Director General Lamy is conducting informal consultations to try and move the process along. An open-ended informal meeting is planned in a few weeks, possibly on 12 March according to one source.

The TRIPS Council meeting was originally scheduled for 2-3 March, but ended a day early.

Bolivia Proposal

Meanwhile, Bolivia has submitted a communication on the article in the TRIPS agreement related to plant variety protection and the patentability of innovations on plants and animals.

This TRIPS Article 27.3(b) was scheduled to be reviewed four years after the implementation of the agreement forming the WTO. But that review stalled and the last official document on it [pdf] dates to March 2006.

More recently, issues of patenting related to plant life have been discussed in relation to a mandate from the 2001 Doha ministerial that the TRIPS Council examine the relationship of TRIPS to the Convention on Biological Diversity (CBD).

The Bolivia submission is related to the country’s adoption of a new constitution in January 2009 that includes provisions on the rights of indigenous peoples, the protection of biodiversity and “prohibition of private appropriation of plants, animals, micro-organisms and any living matter for exclusive use and exploitation.”

Article 27.3(b) does not allow the flexibility not to grant patents on micro-organisms.

Bolivia’s communication also cites the UN Declaration on the Rights of Indigenous Peoples, and says a review of 27.3(b) should take this declaration into account.

It calls for 27.3(b) to prohibit the patenting of life forms, including micro-organisms and gene sequences, ensure the protection of indigenous and local community traditional knowledge and folklore in particular against IP claims over that knowledge, and prevent “anti-competitive practices” that threaten food sovereignty in developing countries.

[Update: A WTO official has said technical cooperation was also discussed at the meeting. Bangladesh has joined Sierra Leone and Uganda in submitting its priority needs to the TRIPS Council, there is a new site at the WTO on the priority needs of least developed countries, and the EU introduced a 61-page update on its technical cooperation projects.]

Share this:

  • Click to share on Twitter (Opens in new window)
  • Click to share on LinkedIn (Opens in new window)
  • Click to share on Facebook (Opens in new window)
  • Click to email this to a friend (Opens in new window)
  • Click to print (Opens in new window)

Related

Kaitlin Mara may be reached at kmara@ip-watch.ch.

Creative Commons License"WTO TRIPS Council Considers Workshop On Public Health Amendment" by Intellectual Property Watch is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

Filed Under: IP Policies, Language, News, Themes, Venues, Biodiversity/Genetic Resources/Biotech, English, Health & IP, Patents/Designs/Trade Secrets, Technical Cooperation/ Technology Transfer, Trademarks/Geographical Indications/Domains, WTO/TRIPS

Trackbacks

  1. GenevaLunch » Blog Archive » WTO workshop cheaper generic drugs in developing countries falls through says:
    03/03/2010 at 4:48 pm

    […] Log-in International organizations ::   WTO workshop cheaper generic drugs in developing countries falls through Excerpt reprinted with permission from Intellectual Property Watch (full article) […]

    Reply
  2. TRIPS Council Discusses Efficacy Of ACTA, Public Health Amendment | Intellectual Property Watch says:
    23/10/2011 at 4:13 pm

    […] Bolivian proposal that opposes patenting life forms (IPW, WTO/TRIPS, 2 March 2010) was also briefly discussed in the TRIPS Council, participants told Intellectual Property Watch, […]

    Reply

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

  • Email
  • Facebook
  • LinkedIn
  • RSS
  • Twitter
  • Vimeo
My Tweets

IPW News Briefs

Saudis Seek Alternative Energy Partners Through WIPO Green Program

Chinese IP Officials Complete Study Of UK, European IP Law

Perspectives on the US

In US, No Remedies For Growing IP Infringements

US IP Law – Big Developments On The Horizon In 2019

More perspectives on the US...

Supported Series: Civil Society And TRIPS Flexibilities

Civil Society And TRIPS Flexibilities Series – Translations Now Available

The Myth Of IP Incentives For All Nations – Q&A With Carlos Correa

Read the TRIPS flexibilities series...

Paid Content

Interview With Peter Vanderheyden, CEO Of Article One Partners

More paid content...

IP Delegates in Geneva

  • IP Delegates in Geneva
  • Guide to Geneva-based Public Health and IP Organisations

All Story Categories

Other Languages

  • Français
  • Español
  • 中文
  • اللغة العربية

Archives

  • Archives
  • Monthly Reporter

Staff Access

  • Writers

Sign up for free news alerts

This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy

Copyright © 2025 · Global Policy Reporting

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.